中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01177 中国生物制药

未开盘 12-15 16:08:35

6.500

-0.300

-4.41%

最高6.800	最低6.490	成交量9,430万
今开6.800	昨收6.800	日振幅4.56%
总市值1,219亿	流通市值1,219亿	总股本187.61亿
成交额6.19亿	换手率0.50%	流通股本187.61亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"中国生物制药","latestPrice":6.5,"timestamp":1765786115002,"preClose":6.8,"halted":0,"volume":94303803,"delay":0,"floatShares":18761000000,"shares":18761000000,"eps":0.2114676029289322,"marketStatus":"未开盘","change":-0.3,"latestTime":"12-15 16:08:35","open":6.8,"high":6.8,"low":6.49,"amount":619452797,"amplitude":0.045588,"askPrice":6.51,"askSize":412000,"bidPrice":6.5,"bidSize":56000,"shortable":3,"etf":0,"ttmEps":0.23635206125545677,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":0,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":6.8,"dividendRate":0.013815,"openAndCloseTimeList":[[1765762200000,1765771200000],[1765774800000,1765785600000]],"volumeRatio":1.50797,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.3707,"impliedVolPercentile":0.1585},"requestUrl":"/m/hq/s/01177/tweets","defaultTab":"tweets","newsList":[{"id":"2591657917","title":"医药行业周报：IN VIVO CART：BD热门赛道 早期技术具备广阔前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2591657917","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591657917?lang=zh_cn&edition=full","pubTime":"2025-12-14 00:00","pubTimestamp":1765641600,"startTime":"0","endTime":"0","summary":"核心观点：In Vivo CART赛道发展火热，2025年已经有四个MNC并购的案例发生。具体来看，In Vivo CART分为LNP和慢病毒两条技术路线，两条技术路线均具备显著特色。LNP路线来看，药物在临床前展现出了快速转染以及优异的靶向性特点，慢病毒路线中，Esobiotec等公司的BCMA In Vivo CART已经在小人群MM患者中展现非常好的早期数据。整体看，In VivoCART发展迅速，后续发展值得关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","LU2242644610.SGD","06821","LU0052750758.USD","06160","LU0708995583.HKD","BK1141","LU0320764599.SGD","02359","01801","LU2125910500.SGD","BK1583","BK1574","LU2045819591.USD","01177","BK1576","LU1046422090.SGD","BK1161"],"gpt_icon":0},{"id":"2590657123","title":"中国生物制药(01177)：库莫西利胶囊获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2590657123","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590657123?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:54","pubTimestamp":1765529678,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 公布，集团自主研发的国家1类创新药库莫西利胶囊  已获得中国国家药品监督管理局  的上市批准，用于与氟维司群联合治疗既往接受内分泌治疗后出现疾病进展的激素受体  阳性、人表皮生长因子受体2  阴性的局部晚期或转移性乳腺癌患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国生物制药(01177)：库莫西利胶囊获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01177","BK1521","BK1191","HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1515","IE00BZ08YS42.EUR","BK1589"],"gpt_icon":0},{"id":"2591382066","title":"每日卖空追踪 | 中国生物制药 12月12日卖空量成交262.3万股，卖空比例为4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591382066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591382066?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528218,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月12日，涨1.04%，卖空量成交262.3万股，较上一交易日减少68.29%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165237a4446a2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165237a4446a2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YS42.EUR","HK0000165453.HKD","BK1515","IE00BZ08YR35.GBP","01177","BK1191","IE00BZ08YT58.USD","BK1521","BK1589"],"gpt_icon":0},{"id":"2590233595","title":"【券商聚焦】交银国际：创新药增量支付空间持续扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2590233595","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590233595?lang=zh_cn&edition=full","pubTime":"2025-12-12 09:02","pubTimestamp":1765501348,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓整体平稳，内外资加大创新药布局的大方向不变。该机构指，本周医保+商保双目录落地，医保谈判新增品种成功率创近年新高，续约品种降价幅度相对温和。该机构认为商保资金的引入将为创新药支付带来重要增量资金，进一步优化多元支付体系。该机构看好医保新纳入品种/适应症在2026年的销售放量，以及首版商保目录的实际执行和支付情况。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971425","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002463.SGD","159992","LU1951186391.HKD","LU0043850808.USD","LU2778985437.USD","HK0000165453.HKD","LU0181495838.USD","LU0516423091.SGD","LU0067412154.USD","LU2097828557.USD","LU0502904849.HKD","LU1226287529.USD","LU0359201612.USD","LU0634319403.HKD","LU1961090484.USD","01801","02142","LU0708995583.HKD","02616","LU0417516738.SGD","BK1161","01877","LU0359202008.SGD","09995","02269","LU1993786604.SGD","LU1969619763.USD","SG9999004220.SGD","01093","LU0540923850.HKD","LU0880133367.SGD","LU2039709279.SGD","BK1588","LU1770034418.SGD","06160","LU0348766576.USD","01177","06185","LU2097828714.EUR","03329","09688","LU2097828631.EUR","LU0456827905.SGD","LU2242644610.SGD","09926","LU2328871848.SGD","IE00B0JY6N72.USD","LU1794554557.SGD","06978","LU1242518931.SGD"],"gpt_icon":0},{"id":"2590475925","title":"港股早知道 | 国际银价续创新高；汇丰：预计美联储明后两年不会降息；云顶新耀与海森生物达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2590475925","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590475925?lang=zh_cn&edition=full","pubTime":"2025-12-12 09:00","pubTimestamp":1765501238,"startTime":"0","endTime":"0","summary":"此前美联储政策制定者以分化的表决结果将利率下调了25个基点。云顶新耀宣布与海森生物达成战略合作，发挥商业化平台的优势与布局2025年12月11日，港股创新药企云顶新耀宣布，其全资附属公司云顶新耀医药科技有限公司已与海森生物医药有限公司签署两项战略合作协议：商业化服务协议以及授权许可协议。本次增持后，朱江明及傅利泉与所属的单一最大股东集团合共持有公司2.09亿股H股及1.29亿股内资股，占公司已发行总股数的23.75%。","market":"hk","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380662.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09863","BK1191","BK1183","BK1564","IE00BZ08YT58.USD","BK1574","06099","BK1583","01177","09969","02670","HK0000165453.HKD","BK1589","BK1119","BK1147","BK1521","BK1161","IE00BZ08YS42.EUR","01952","IE00BZ08YR35.GBP","BK1515"],"gpt_icon":0},{"id":"2590523693","title":"中国生物制药12月11日主力净流出1010.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590523693","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590523693?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440905,"startTime":"0","endTime":"0","summary":"12月11日, 中国生物制药股价跌0.59%，报收6.73元，成交金额3.7亿元，换手率0.29%，振幅2.95%，量比0.96。中国生物制药今日主力资金净流出1010.4万元，上一交易日主力净流入2431.3万元。该股近5个交易日下跌1.45%，主力资金累计净流出1034.3万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入6392.5万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211161530a6990888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211161530a6990888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1589","01177","IE00BZ08YT58.USD","HK0000165453.HKD","BK1521","BK1515"],"gpt_icon":0},{"id":"2590807575","title":"每日卖空追踪 | 中国生物制药 12月10日卖空量成交456.3万股，卖空比例为9.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590807575","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590807575?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355419,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月10日，跌1.46%，卖空量成交456.3万股，较上一交易日减少68.4%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016325395353c64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016325395353c64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","IE00BZ08YT58.USD","01177","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1589","BK1521","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2590305967","title":"交银国际：医保商保目录落地 多元支付体系创新药增量空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2590305967","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590305967?lang=zh_cn&edition=full","pubTime":"2025-12-10 14:26","pubTimestamp":1765348009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，予内地医药行业领先评级。国家医保局召开“2025年创新药高质量发展大会”，正式公布本轮医保谈判和商保创新药目录协商结果。同时，商保资金的引入将为创新药支付带来重要增量资金，未来商业健康险有望与基本医保错位发展，为多元化支付体系的建立奠定基础。该行看好新纳入品种/适应症在2026年的销售增长潜力，尤其是康方生物等潜在大单品的增量释放空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01177","LU2097828714.EUR","BK1589","BK1574","LU1961090484.USD","159992","BK1521","IE00B543WZ88.USD","LU2097828557.USD","LU0634319403.HKD","BK1515","HK0000165453.HKD","LU0540923850.HKD","LU2097828474.EUR","LU2097828805.USD","LU0359201612.USD","01276","LU0348827113.USD","LU0348783233.USD","IE00BZ08YS42.EUR","LU0348767384.USD","LU0359201885.HKD","LU2242644610.SGD","LU0348825331.USD","03329","LU0417516902.SGD","BK1191","LU0417516738.SGD","LU0561508036.HKD","LU2488822045.USD","01801","IE00B5MMRT66.SGD","LU2399975544.HKD","LU0417516571.SGD","LU0348784397.USD","LU2097828631.EUR","06978","LU2476274308.USD","BK1147","LU0359202008.SGD","LU0348766576.USD","BK1161","LU2328871848.SGD","LU2778985437.USD","LU1969619763.USD","LU0502904849.HKD","09926","IE00BPRC5H50.USD","BK1583","LU0348735423.USD"],"gpt_icon":0},{"id":"2590393913","title":"招银国际：2025医保目录公布延续支持创新 料CXO业下半年修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2590393913","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590393913?lang=zh_cn&edition=full","pubTime":"2025-12-09 10:03","pubTimestamp":1765245827,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，2025年版基本医保目录以及首版商保目录发布，延续支持创新，料CXO行业有望在下半年迎来业绩修复。推荐买入三生制药(01530)、固生堂(02273)、药明合联(02268)、巨子生物(02367)、信达生物(01801)、中国生物制药(01177)。报告表示，多家企业的核心创新品种获纳入医保。该行认为，宏观环境及老龄化的挑战下，医保收支压力仍在，关注国家集采续约。尽管首版商保目录短期对于产品销售的拉动有限，由于商业保险的规模不大，认为商保目录的意义重大，或将开启中国商业医疗保险扩容的道路，成为中国多元化支付体系发展开端。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","BK1191","BK1589","SG9999004311.SGD","SG9999014674.SGD","HK0000165453.HKD","IE00BZ08YT58.USD","LU2097828557.USD","LU2097828805.USD","BK1593","LU2097828631.EUR","LU2488822045.USD","IE00BZ08YS42.EUR","01801","01530","BK1521","LU2242644610.SGD","02367","LU1969619763.USD","01177","LU0502904849.HKD","LU2097828714.EUR","BK1583","02273","BK1161","LU2097828474.EUR","BK1141","02268","LU0455707207.USD","LU2328871848.SGD","BK1515","CXO","IE00BZ08YR35.GBP","BK1207"],"gpt_icon":0},{"id":"2590367035","title":"【券商聚焦】交银国际：2025年医保+商保双目录落地 多元支付体系盘活创新药增量空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2590367035","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590367035?lang=zh_cn&edition=full","pubTime":"2025-12-09 08:59","pubTimestamp":1765241994,"startTime":"0","endTime":"0","summary":"调整后的目录中，药品总数增至3,253种。新版目录将于2026年1月1日正式实施。该机构认为，更多新药进入目录有助于提升临床用药水平，及创新药行业整体研发回报率；商保资金的引入将为创新药支付带来重要增量资金，为多元化支付体系的建立奠定基础。百济有两款产品纳入商保创新药目录，信达、和黄各有一款纳入。同时重点关注首批商保目录的实际执行和支付情况、名单及定价的动态调整以及真实世界数据积累带来的长期发展机会。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971149","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572944931.SGD","LU0327786744.USD","LU0140636845.USD","LU1951186391.HKD","LU0348767384.USD","BK1588","02616","159992","LU0708995583.HKD","LU1720050803.USD","01877","LU1770034418.SGD","BK1161","LU0456827905.SGD","02142","06160","06978","LU1226288170.HKD","LU0348766576.USD","LU2399975544.HKD","02269","LU1813983027.USD","01801","BK1576","LU0348783233.USD","LU1969619763.USD","BK1574","BK1610","LU0181495838.USD","LU0348784397.USD","BK1141","IE00B0JY6N72.USD","LU0880133367.SGD","BK1147","IE00B543WZ88.USD","09926","LU2039709279.SGD","01177","IE00BZ08YR35.GBP","LU0516423091.SGD","LU0417516902.SGD","LU1719994722.HKD","LU2476274308.USD","09688","LU0326950275.SGD","01093","06185","BK1191","03329","09995"],"gpt_icon":0},{"id":"2590350406","title":"每日卖空追踪 | 中国生物制药 12月08日卖空量成交418.9万股，卖空比例为6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590350406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590350406?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182618,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月08日，跌0.88%，卖空量成交418.9万股，较上一交易日减少31.69%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081632419531088e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081632419531088e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YR35.GBP","BK1589","HK0000165453.HKD","01177","BK1515","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK1521","BK1191"],"gpt_icon":0},{"id":"2590504053","title":"中国生物制药12月08日主力净流出3288.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590504053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590504053?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181755,"startTime":"0","endTime":"0","summary":"12月08日, 中国生物制药股价跌0.88%，报收6.78元，成交金额4.7亿元，换手率0.37%，振幅3.07%，量比1.45。中国生物制药今日主力资金净流出3288.7万元，上一交易日主力净流入170.2万元。该股近5个交易日下跌1.45%，主力资金累计净流出6306.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入5375.9万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816213897960cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816213897960cf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","01177","BK1515","IE00BZ08YS42.EUR","HK0000165453.HKD","BK1521","IE00BZ08YR35.GBP","BK1191","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2589815492","title":"每日卖空追踪 | 中国生物制药 12月05日卖空量成交398.2万股，卖空比例为8.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589815492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589815492?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:30","pubTimestamp":1764923417,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月05日，跌0.58%，卖空量成交398.2万股，较上一交易日减少49.86%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205163221a4ce658c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205163221a4ce658c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YR35.GBP","BK1589","BK1521","BK1515","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1191","01177","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2589581541","title":"多个减重药物迎来新进展，涉及中国生物制药、信达生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2589581541","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589581541?lang=zh_cn&edition=full","pubTime":"2025-12-05 15:58","pubTimestamp":1764921480,"startTime":"0","endTime":"0","summary":"全球超6.5亿人受肥胖困扰，中国减肥药市场潜力巨大，GLP-1类药物市场增速超全球平均。国内药企积极布局并实现突破，12月4日，中国生物制药自主研发的TQF3250胶囊临床试验申请获中美批准，该药是口服小分子偏向型GLP-1受体激动剂，有望实现更优血糖与体重控制，降低副作用，提升用药便利性。11月20日，信达生物宣布玛仕度肽III期临床研究达成主要终点，25日其高剂量9mg上市申请获受理，该药可显著减轻体重、改善代谢指标，且耐受性和安全性良好。此外，常山药业、派格生物等也有GLP-1类药物处于上市申请阶段。国内药企的突破得益于政策、研发和市场需求的驱动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161052a4ce58cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161052a4ce58cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1521","IE00BZ08YS42.EUR","BK1161","LU2328871848.SGD","BK1589","BK1515","LU2097828631.EUR","HK0000165453.HKD","LU2097828557.USD","LU2242644610.SGD","IE00BZ08YT58.USD","LU2097828714.EUR","LU1969619763.USD","01801","BK1583","BK1191","LU2097828805.USD","01177","IE00BZ08YR35.GBP","LU0455707207.USD","LU0502904849.HKD","LU2097828474.EUR"],"gpt_icon":0},{"id":"2589858867","title":"一周内，3款国产新药临床试验申请已获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2589858867","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589858867?lang=zh_cn&edition=full","pubTime":"2025-12-05 11:36","pubTimestamp":1764905760,"startTime":"0","endTime":"0","summary":"近年来中国医药产业加速向“全球创新”转型，国产创新药密集申请FDA临床，一周内3款国产新药临床试验申请获FDA批准。中国生物制药TQF3250胶囊获中美批准，拟用于减重，治疗2型糖尿病申请也获NMPA批准，其有望实现更优血糖与体重控制；石药集团SYH2056片获FDA批准在美国开展临床试验，该药为选择性5-HT2A受体激动剂，用于治疗抑郁症，单次给药快速起效且无致幻风险；和誉药业ABSK141获FDA批准，用于治疗携带KRASG12D突变的晚期实体瘤患者，此次获批旨在评估其安全性等。国产创新药闯关FDA，标志着中国创新药产业迈向新阶段，企业管线质量提升，未来几年将是成果密集验证期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205114715952c07ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205114715952c07ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1807302812.USD","LU0140636845.USD","LU0315179316.USD","BK1521","IE00BZ08YR35.GBP","LU0067412154.USD","LU1960683339.HKD","LU0501845795.SGD","LU0880133367.SGD","LU1951186391.HKD","LU2039709279.SGD","LU1226287875.USD","LU1008478684.HKD","01093","IE00B031HY20.USD","LU1993786604.SGD","LU1226287529.USD","LU1226288253.USD","IE00B543WZ88.USD","SG9999004220.SGD","IE00BZ08YS42.EUR","LU1226288170.HKD","IE0008369823.USD","LU1152091754.HKD","IE0008368742.USD","BK1191","LU1226287792.SGD","LU0072913022.USD","HK0000165453.HKD","LU0326950275.SGD","LU1152091168.USD","IE00BZ08YT58.USD","LU1328277881.USD","IE00B5MMRT66.SGD","01177","LU0314109678.HKD","LU1813983027.USD","BK1515"],"gpt_icon":0},{"id":"2588007417","title":"中国生物制药(01177)：TQF3250“口服偏向型GLP-1受体激动剂”临床试验申请获NMPA、FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2588007417","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588007417?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:27","pubTimestamp":1764840424,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，集团自主研发的创新药TQF3250胶囊“口服偏向型GLP-1受体激动剂”的临床试验申请已获得中国国家药品监督管理局和美国食品药品监督管理局的批准，拟用于减重。TQF3250是一款口服小分子偏向型GLP-1受体激动剂。与传统GLP-1药物相比，TQF3250通过选择性激活cAMP偏向的GLP-1受体信号通路，促进胰岛素分泌，同时减少β-arrestin募集和受体内吞，从而延长药效持续时间。除减重适应症外，TQF3250用于治疗2型糖尿病的临床试验申请已获NMPA批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4590","BK1191","BK4144","IE00BZ08YS42.EUR","GLP","01177","BK1521","IE00BZ08YT58.USD","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1515","BK1589"],"gpt_icon":0},{"id":"2588076380","title":"【券商聚焦】中泰国际：北京与上海相继出台政策支持创新医疗器械的开发 料有利于创新医疗器械板块发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2588076380","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588076380?lang=zh_cn&edition=full","pubTime":"2025-12-04 09:04","pubTimestamp":1764810245,"startTime":"0","endTime":"0","summary":"医疗器械板块上涨，该机构估计是由于北京与上海相继出台政策支持创新医疗器械开发。北京出台《北京市促进医疗器械产业高质量发展若干措施》，提出多条举措支持创新器械的临床研发、注册上市、销售推广、产业链发展和出海。该机构认为以上政策有利于创新医疗器械板块的发展，但港股大型创新医疗器械生产商不多，该机构对传统医疗器械生产商的2025年业绩偏谨慎。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970861","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828805.USD","LU2488822045.USD","IE00B0JY6N72.USD","LU0516423174.USD","02359","02269","LU0051755006.USD","01801","01177","01066","HK0000165453.HKD","LU1969619763.USD","LU0140636845.USD","BK1583","LU0359202008.SGD","LU2045819591.USD","LU0516423091.SGD","BK1161","09996","BK1100","LU0455707207.USD","LU3063872942.SGD","LU0307460666.USD","LU1880383366.USD","LU0348735423.USD","BK1141","LU0823426308.USD","LU0173614495.USD","IE00BZ08YT58.USD","SG9999002463.SGD","LU0359201612.USD","LU2125910500.SGD","LU0823426480.USD","LU0348825331.USD","09997","LU2039709279.SGD","LU2097828631.EUR","BK1574","159883","LU0708995583.HKD","LU2328871848.SGD","03692","LU0456846285.SGD","LU2097828474.EUR","LU2097828714.EUR","BK1191","LU2242644610.SGD","LU0856984785.SGD","LU0456827905.SGD","LU0819121731.USD"],"gpt_icon":0},{"id":"2589306028","title":"中美监管机构同时亮绿灯，中国生物制药TQF3250减重适应症临床试验申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2589306028","media":"正大制药订阅号","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589306028?lang=zh_cn&edition=full","pubTime":"2025-12-04 07:02","pubTimestamp":1764802926,"startTime":"0","endTime":"0","summary":"12月1日，中国生物制药1类新药TQF3250胶囊的临床试验申请获美国食品药品监督管理局批准，拟用于减重适应症。TQF3250具备独特的偏向型机制，除减重领域外，用于治疗2型糖尿病的临床试验申请已于近日正式获批。此外，TQF3250口服给药的方式相比于主流GLP-1药物的注射剂型，大幅提升了患者用药的便利性和长期治疗依从性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204070534a4cb30ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204070534a4cb30ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YT58.USD","BK1191","BK1521","BK1515","HK0000165453.HKD","01177","IE00BZ08YS42.EUR","BK1589","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2588173047","title":"港股公告掘金 | 英诺赛科与安森美半导体达成共同加速推进氮化镓产业生态建设的战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2588173047","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588173047?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:58","pubTimestamp":1764773894,"startTime":"0","endTime":"0","summary":"【重大事项】京东工业(07618)拟全球发售2.11亿股 预计12月11日上市中国燃气(00384)坚持“绿色城市运营商”战略方向构建多能互补的能源体系协同生态及与亿纬锂能订立战略合作协议中核国际(02302)间接控股母公司中国铀业正式登陆深交所 有力彰显其资本市场地位的提升英诺赛科(02577)与安森美半导体达成共同加速推进氮化镓产业生态建设的战略合作协议英诺赛科(02577)于与英飞凌的诉讼案","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00384","LU1978683503.SGD","BK1521","BK4585","BK1124","07618","IE00BZ08YS42.EUR","LU1861214812.USD","LU1861219969.SGD","BK1221","LU0124384867.USD","BK1589","BK1163","02577","BK1566","BK1515","LU0348723411.USD","BK4588","HK0000165453.HKD","IE00BZ199S13.USD","LU1720051017.SGD","LU1861215975.USD","IE00BD6J9T35.USD","BK4512","LU0640798160.USD","IE00BZ08YT58.USD","ON","BK4605","02302","BK1191","LU1854103824.USD","LU2357305700.SGD","BK4141","BK1500","LU1720051108.HKD","LU2360107325.USD","LU1548497426.USD","LU0724618433.USD","01177","IE00BZ08YR35.GBP","LU2298322129.HKD","LU1854104046.USD","LU1861220033.SGD","IE00BFMHRM44.USD","LU1115378108.SGD"],"gpt_icon":0},{"id":"2588019669","title":"中国生物制药(01177)：罗替高汀贴片获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2588019669","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588019669?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:37","pubTimestamp":1764751048,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，集团开发的“罗替高汀贴片”已获得中国国家药品监督管理局的上市批准，用于早期特发性帕金森病症状及体征的单药治疗，或与左旋多巴联合用于病程中的各个阶段。罗替高汀贴片已被纳入《中国帕金森病治疗指南》等多部指南及共识，成为早发型帕金森病的初期治疗推荐用药。目前，集团管线内还有十余款贴剂产品有望于2030年前获批上市，进一步巩固集团在透皮贴剂领域的领导地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377036.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国生物制药(01177)：罗替高汀贴片获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01177","BK1191","BK1521","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1589","BK1515"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinobiopharm.com","stockEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0173},{"period":"3month","weight":-0.2121},{"period":"6month","weight":0.2466},{"period":"1year","weight":1.0335},{"period":"ytd","weight":1.1546}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国生物制药有限公司是一家主要从事制药业务的投资控股公司。该公司通过三个分部运营。中药现代制剂及西药分部主要从事生产、销售及配销中药现代制剂及西药产品业务。投资分部主要从事长期投资业务。其他分部主要从事相关医疗及医院业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.409091,"avgChangeRate":0.005246},{"month":2,"riseRate":0.681818,"avgChangeRate":0.063302},{"month":3,"riseRate":0.590909,"avgChangeRate":0.048254},{"month":4,"riseRate":0.5,"avgChangeRate":0.025891},{"month":5,"riseRate":0.727273,"avgChangeRate":0.043347},{"month":6,"riseRate":0.363636,"avgChangeRate":0.00957},{"month":7,"riseRate":0.636364,"avgChangeRate":0.047691},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.010062},{"month":9,"riseRate":0.409091,"avgChangeRate":-0.015174},{"month":10,"riseRate":0.545455,"avgChangeRate":0.025184},{"month":11,"riseRate":0.5,"avgChangeRate":0.066781},{"month":12,"riseRate":0.409091,"avgChangeRate":-0.007753}],"exchange":"SEHK","name":"中国生物制药","nameEN":"SINO BIOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国生物制药,01177,中国生物制药股票,中国生物制药股票老虎,中国生物制药股票老虎国际,中国生物制药行情,中国生物制药股票行情,中国生物制药股价,中国生物制药股市,中国生物制药股票价格,中国生物制药股票交易,中国生物制药股票购买,中国生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}